| Code | Description | Claims | Beneficiaries | Total Paid |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,006 |
603 |
$9K |
| 99205 |
Prolong outpt/office vis |
812 |
794 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
746 |
688 |
$2K |
| 99215 |
Prolong outpt/office vis |
1,553 |
1,214 |
$2K |
| 71048 |
|
889 |
846 |
$708.38 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
235 |
113 |
$441.24 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
298 |
282 |
$121.94 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
28 |
28 |
$105.99 |
| 87634 |
|
174 |
169 |
$62.39 |
| 90836 |
|
193 |
170 |
$56.02 |
| 94010 |
|
201 |
199 |
$49.20 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
33 |
31 |
$42.01 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
200 |
198 |
$31.19 |
| 99403 |
|
160 |
130 |
$23.50 |
| 93000 |
|
45 |
43 |
$3.01 |
| 99404 |
|
79 |
73 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
73 |
62 |
$0.00 |
| 87561 |
|
208 |
204 |
$0.00 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
91 |
90 |
$0.00 |
| 99402 |
|
57 |
52 |
$0.00 |